Atlas Trials

Phase II Randomised Trial of Cyclophosphamide & Dexamethasone in Combination With Ixazomib in Relapsed or Refractory Multiple Myeloma.

Clinical trial NCT02461888 · COMPLETED

Trial details

NCT number
NCT02461888
Sponsor
University of Leeds
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Multiple Myeloma
Start date
2015-12-01
Primary completion
2022-04-01
Enrollment
112

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.